Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  nelfinavir mesylate
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Combination Chemotherapy with or without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients with Locally Advanced Pancreatic Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 441-13, NCI-2013-02273, NCI-2012-00835, NCI-2013-02118, NCT01959672
Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients with Oligometastases
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J12137, NCI-2013-01342, CIR00009753, NA_00069585, NCT01728779
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 01309, NCI-2009-01355, IRB#809463, NCT00915694
Nelfinavir Mesylate in Treating Patients with Epstein-Barr Virus or Kaposi Sarcoma-Associated Herpesvirus Positive Malignancies
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J13174, NCI-2014-01534, NA_00092477, NA _00092477 / CIR00004163, NCT02080416
Start Over